Download Citation
Article Source:
Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy
Wu J,
Du J,
Liu L,
Li Q,
Rong W,
et al.
(2012)
Elevated Pretherapy Serum IL17 in Primary Hepatocellular Carcinoma Patients Correlate to Increased Risk of Early Recurrence after Curative Hepatectomy.
PLOS ONE 7(12): e50035.
https://doi.org/10.1371/journal.pone.0050035